Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	10.57	93.99	85.00
Graham Fair Price	-59.12	1.51	3.69
PEG	808.52	-0.17	0.02
Price/Book	-1.18	0.46	0.47
Price/Cash Flow	-464.98	-11.02	-1.95
Prices/Earnings	483.99	20.22	-3.46
Price/Sales	11.41	0.80	0.72
Price/FCF	-464.98	-11.02	-1.95
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-25.22	0.11	0.15
Operating Margin	-23.21	0.04	-0.05
ROA	-83.35	< 0.005	< 0.005
ROE	-0.03	< 0.005	-83.08
ROIC	< 0.005	< 0.005	-60.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.04	-25.88
Dividends QOQ	0.77	-0.41	-47.50
EBIT QOQ	-1.37	1.68	22.41
EPS QOQ	-1.82	1.17	-35.72
FCF QOQ	-5.39	0.83	-84.65
Revenue QOQ	-0.14	-0.12	12.23
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	19.33	26.12	35.15
Days Sales Outstanding (DSO)	70.28	86.56	23.18
Inventory Turnover	4.66	3.45	-26.01
Debt/Capitalization	0.82	0.83	0.69
Quick Ratio	0.58	0.63	7.97
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.22	4.19	-0.62
Cash	3.05	3.11	1.93
Capex	-1.29	-0.70	46.11
Free Cash Flow	-1.02	-0.18	82.62
Revenue	2.77	2.44	-11.85
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.68	0.75	10.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	75.88	84.38	11.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating